Insider · CIK 0002109011
Jason Silvers
Files at GENB (Generate Biomedicines, Inc.). First filing Mar 2, 2026, latest Mar 2, 2026.
In brief
Jason Silvers files SEC Form 4 as CFO and president at GENB (Generate Biomedicines, Inc.). Since Mar 2, 2026, Jason Silvers has reported 1 open-market buy worth $32k and 0 open-market sells worth $0, the latest filed on Mar 2, 2026.
A track record needs three past buys with six months of prices behind them; Jason Silvers has 0, so none is measured yet.
The newest scored trade: bought $32k of GENB on Mar 2, 2026, filed Mar 2, 2026, scored 60 (notable). In the last 12 months: 1 buy worth $32k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GENB: Generate Biomedicines, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Generate Biomedicines, Inc. | $32k 2,000 shares | - | 0% from low-4% from high |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | GENB Generate Biomedicines, Inc. | POpen-market purchase Common Stockindirect: By daughter | +500 | $16.00 | $8,000 | 500 | Mar 2, 2026 |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc. | POpen-market purchase Common Stockindirect: By daughter | +500 | $16.00 | $8,000 | 500 | Mar 2, 2026 |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc. | POpen-market purchase Common Stockindirect: By son | +1,000 | $16.00 | $16k | 1,000 | Mar 2, 2026 |
| Feb 26, 2026 | GENB Generate Biomedicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +295,608 | $0.00 | $0 | 295,608 | Mar 2, 2026 |
| Feb 26, 2026 | GENB Generate Biomedicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +274,493 | $0.00 | $0 | 274,493 | Mar 2, 2026 |
Questions about Jason Silvers
Answered from the filings on this page, as of the latest one.
Is Jason Silvers buying or selling?
In the last 12 months Jason Silvers reported 1 open-market buy worth $32k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $32k of GENB on Mar 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Jason Silvers's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jason Silvers has 0.
Where does Jason Silvers file Form 4?
Jason Silvers has filed Form 4 at GENB (Generate Biomedicines, Inc.) as President & CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.